跳至主要内容
临床试验/NCT06171529
NCT06171529Enrolling By Invitation不适用

Efficacy of a Single Injection of Connective Tissue Matrix for Post-Operative CMC Arthritis

Indiana Hand to Shoulder Center2 个研究点 分布在 1 个国家目标入组 50 人开始时间: 2023年3月7日最近更新:
适应症

试验速览

阶段
不适用
状态
Enrolling By Invitation
入组人数
50
试验地点
2
主要终点
Narcotic Use

研究概览

简要总结

The goal of this study is to determine the success rate of a single Carpometacarpal (CMC) thumb injection after arthroplasty surgery for primary osteoarthritis of the CMC joint.

详细描述

CTM Biomedical markets and distributes decellularized particulate human placental connective-tissue matrix products, intended solely for homologous use to supplement or replace damaged or inadequate connective-tissue. These are structural tissue allografts processed according to the criteria contained in 21CFR 1271.10(a) for regulation solely under section 361 of the Public Health Service Act. CTM Flow is decellularized particulate human placental connective-tissue matrix provided in a vial.

Postoperative pain after basilar thumb arthritis reconstruction is often quite significant. CTM flow is an extracellular matrix implant that supplements and replaces damaged tissues. Small unpublished case series in total knee arthroplasty, ENT procedures, and rotator cuff repair have shown beneficial results from CTM. We hope to show similar results in this assessment of CTM in the Post-operative CMC arthroplasty patient population.

The primary outcome measure will be narcotic use postoperatively in the first 3 weeks after surgery, as measured by patient tracking. Patients will track post-op pain meds including narcotics, and OTC pain medication for the duration of their follow up period. Per standard of care, patients will be encouraged to change to Tylenol and/or ibuprofen pain medicine as soon as they are able.

Secondary outcomes will be quickDASH and VAS pain.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Single Group
主要目的
Treatment
盲法
Double (Participant, Investigator)

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Males or females age 18 or older
  • Patients presenting for basilar thumb reconstruction surgery (any surgical technique)
  • Patients who can consent to be a part of this study
  • Patients who are able to return to the Indiana Hand to Shoulder Center or satellite location for follow up time points

排除标准

  • Additional procedures at the same time
  • Patients with previous basilar thumb reconstruction on the operative side (revision surgery)
  • Chronic narcotic use
  • Women who are pregnancy or breastfeeding
  • Non-English speaking

结局指标

主要结局

Narcotic Use

时间窗: 6 Weeks

number of narcotic medications taken in recover

次要结局

  • VAS Pain(6 Months)
  • quickDASH(6 Months)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验

Efficacy of a Single Injection of CTM for... | 临床试验